Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
3.240
+0.060 (1.89%)
May 14, 2025, 9:30 AM - Market open

Revelation Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
3.76.511.995.251.274.49
Cash & Short-Term Investments
3.76.511.995.251.274.49
Cash Growth
-74.54%-45.80%128.28%312.09%-71.63%-
Prepaid Expenses
0.220.070.080.070.640.13
Other Current Assets
--0.070.09--
Total Current Assets
3.936.5712.155.411.914.62
Property, Plant & Equipment
0.040.060.070.090.13-
Total Assets
3.976.6212.215.52.044.62
Accounts Payable
0.630.781.360.550.60.87
Accrued Expenses
0.461.131.150.991.530.34
Current Portion of Leases
----0.02-
Other Current Liabilities
003.052.91--
Total Current Liabilities
1.091.915.564.452.141.21
Total Liabilities
1.091.915.564.452.141.21
Common Stock
000000
Additional Paid-In Capital
45.4445.2132.1126.414.425.54
Retained Earnings
-42.56-40.51-25.47-25.35-14.52-2.53
Total Common Equity
2.884.716.651.05-0.13.01
Shareholders' Equity
2.884.716.651.05-0.13.41
Total Liabilities & Equity
3.976.6212.215.52.044.62
Total Debt
----0.02-
Net Cash (Debt)
3.76.511.995.251.264.49
Net Cash Growth
-74.54%-45.80%128.28%317.57%-72.00%-
Net Cash Per Share
9.3237.89841.76---
Filing Date Shares Outstanding
0.970.910.1-0-
Total Common Shares Outstanding
0.970.520.02---
Working Capital
2.844.656.580.96-0.233.41
Book Value Per Share
2.979.02402.06---
Tangible Book Value
2.884.716.651.05-0.13.01
Tangible Book Value Per Share
2.979.02402.06---
Machinery
-0.150.130.130.13-
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q